Aller au contenu principal
2023 review

S280 The Efficacy and Safety of Vibrating Capsules for Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

0Citations signalées — pas une note de qualité
4Institutions déclarées
2Pays d’affiliation déclarés

Résumé fourni par la source

Introduction: Chronic idiopathic constipation (CIC) is a prevalent worldwide functional gastrointestinal disorder that remains challenging to treat. Pharmacologic therapy, such as laxatives and dietary fibers are suggested as lines of treatment. However, these lines are not effective enough. Novel emergent orally ingested vibrating capsules (VC) are introduced as a possible line for management for CIC. Methods: We conducted a literature search in English on electronic databases CENTRAL, PubMed, EMBASE, Scopus, and WOS until February 27th, 2023. RevMan was used to pool dichotomous outcomes as risk ratios (RRs) and continuous outcomes as mean differences (MDs), with 95% confidence intervals (CIs). The study protocol was registered in PROSPERO with ID: (CRD42023409422). Results: Three RCTs with a total of 601 patients were included in our analysis. There was no difference between the VC and placebo in increased complete spontaneous bowel movements (CSBM) (responder rate) (RR: 1.37 with 95% CI [0.82, 2.28], P = 0.22), CSBM change (MD: 0.21 with 95% CI [-0.26, 0.69], P=0.38), spontaneous bowel movement (SBM) change (MD: 0.14 with 95% CI [-0.22, 0.49], P= 0.46), and the incidence of any adverse event (RR: 1.45 with a 95% CI of [0.79, 2.63], P = 0.23). However, VC was associated with increased vibration sensation (RR: 17.23, 95% CI [3.29, 90.20], P = 0.0008) (Figure 1). Conclusion: VC may positively impact improving bowel movements and relieving symptoms of CIC. Our findings suggest that VC is safe and well-tolerated, with no significant harmful effects observed. However, more research is needed to confirm these results and determine the most effective dose, frequency, and duration of treatment for VC to maximize their benefits without compromising safety.Figure 1.: Illustrates efficacy of VC vs Placebo.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
S280 The Efficacy and Safety of Vibrating Capsules for Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Date Crossref
01/10/2023
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Gastrointestinal motility and disorders

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.